Michigan 340B hospitals say drug manufacturers are lobbying state lawmakers to erase language from a new state law that the hospitals say stops the drug makers from imposing claims submission requirements as a condition for 340B pricing.

Drug Makers Ask Michigan Lawmakers to Erase Section from New 340B State Law

Drug manufacturers are asking Michigan state legislators to erase language in a new state law that Michigan hospitals say bars the companies from withholding 340B pricing if a covered entity refuses to hand over its contract pharmacy claims data, 340B Report has learned.

Pharmaceutical Research and Manufacturers of America (PhRMA) yesterday declined to address its lobbying efforts. It said, though, that “claims modifiers and other claims-level data are critical to increasing transparency and ensuring the integrity of the 340B program.”

Drug manufacturers are asking Michigan state legislators to erase language in a new state law that Michigan hospitals say bars the companies from withholding 340B pricing if a covered entity refuses to hand over its contract pharmacy claims data, 340B Report has learned.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report